UnemoMRossJSerwinA, et al.European guideline for the diagnosis and treatment of gonorrhea in adults. Int J STD AIDS2020: 956462420949126. DOI: 10.1177/0956462420949126Epub ahead of print.
2.
BignellCUnemoM. The European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhea in adults. Int J STD AIDS2013; 24: 85–92.
HookEWKirkcaldyRD. A brief history of evolving diagnostics and therapy for gonorrhea: lessons learned. Clin Infect Dis2018; 67: 1294–1299.
5.
WiTLahraMMNdowaF, et al.Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med2017; 14: e1002344.
6.
CyrSt.SBarbeeLWorkowskiKA, et al.Update to CDC’s Treatment Guidelines for Gonococcal Infection. MMWR Morb Mortal Wkly Rep2020; 69: 1911–1916. 2020.
7.
TheuretzbacherUBarbeeLConnollyK, et al.Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities. Clin Microbiol Infect2020; 26: 1630–1635.
8.
GeislerWMUniyalALeeJY, et al.Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. N Engl J Med2015; 373: 2512–2521.
9.
MitchellSJEngelmanJKentCK, et al.Azithromycin-Resistant Syphilis Infection: San Francisco, California, 2000-2004. Clin Infect Dis2006; 42: 337–345.
10.
SoniSHornerPRaymentM, et al.British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS2019; 30: 938–950.
11.
Ndeikoundam NgangroNViriotDFournetN, et al.Bacterial sexually transmitted infections in France: recent trends and patients' characteristics in 2016. Euro Surveill2019; 24: 1800038.
12.
PoncinTFouéréSBrailleA, et al.Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France. Euro Surveill2018; 23: 1800264.
13.
PoncinTMerimecheMBrailleA, et al.Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019. Euro Surveill2019; 24: 1900528.
14.
FouéréSBertolottiABerçotB, et al.Treatment of Neisseria gonorrhoeae infections in France: status report and comparison with European and International recommendations. Ann Dermatol Venereol2020; 147suppl: A291–A292. (French).
15.
JanierMLassauFDupinN, et al.Gonococcie [Gonococcus]. Ann Dermatol Venereol2016; 143: 710–712. (French).
16.
HanYYinYDaiX, et al.Widespread use of high-dose ceftriaxone therapy for uncomplicated gonorrhea without reported ceftriaxone treatment failure: results from 5 years of multicenter surveillance data in China. Clin Infect Dis2020; 70: 99–105.
17.
GeorgeCRREnriquezRPGatusBJ, et al.Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific,2011 to 2016. PLoS ONE2019; 14: e0213312.
